Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma

- PST-Gold nanoparticles showed a robust antitumor activity by the reduction of tumor burden.
- Increase in overall survival and life span in tumor challenged mice.
- The gold nanoconjugates were also very effective than its parental drug.
- Further studies, including clinical trials are warranted on this nanoconjugate.